oxycodone twice-daily formulation oxygesic prolonged-release tablets (Mundipharma gmbh)
Structured Review

Oxycodone Twice Daily Formulation Oxygesic Prolonged Release Tablets, supplied by Mundipharma gmbh, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/oxycodon+tablets+oxygesic/oxycodone+oxycontin/pmc07214637-39-11-20
Average 90 stars, based on 1 article reviews
Images
1) Product Images from "Once‐Daily Oxycodone Prolonged‐Release Tablets Are Resistant to Alcohol‐Induced Dose Dumping: Results From a Randomized Trial in Healthy Volunteers"
Article Title: Once‐Daily Oxycodone Prolonged‐Release Tablets Are Resistant to Alcohol‐Induced Dose Dumping: Results From a Randomized Trial in Healthy Volunteers
Journal: Clinical and Translational Science
doi: 10.1111/cts.12737
Figure Legend Snippet: Mean (arithmetic) plasma oxycodone concentration against time for oxycodone once‐daily (OOD) and oxycodone twice‐daily (OTD) treatments.
Techniques Used: Clinical Proteomics, Concentration Assay
Figure Legend Snippet: Maximum plasma drug concentration (C max ) ratio between alcohol treatments and water treatments with 90% confidence intervals. The reference treatment is that drug’s water condition. OOD, oxycodone once‐daily; OTD, oxycodone twice‐daily.
Techniques Used: Clinical Proteomics, Concentration Assay
Related Articles
other:Article Title: The role of intercostal nerve preservation in pain control after thoracotomy. Article Snippet: Patients who did not receive TEA were managed either using patient controlled analgesia or |